Vimarsana
Biggest News Aggregation in the World

Page 11 - Dan Witters News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Witters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Witters Today - Breaking & Trending Today

Survey Finds Sharpest Decline in Public Opinion About Health Care in the US - Vimarsana News

Survey Finds Sharpest Decline in Public Opinion About Health Care in the US

"Covid really illustrated just how dysfunctional the system actually is,” said one survey respondent.

Americans Struggling With High Cost of Prescription Drugs - Vimarsana News

Americans Struggling With High Cost of Prescription Drugs

An estimated 15.5 million U.S. adults younger than 65 years went without medication due to high drug costs.

Most Americans support Medicare negotiation despite claims it would hurt innovation - Vimarsana News

Most Americans support Medicare negotiation despite claims it would hurt innovation

A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare.

Most Americans Support Medicare Negotiation for Drug Prices Despite Claims It Would Hurt Innovation - Vimarsana News

Most Americans Support Medicare Negotiation for Drug Prices Despite Claims It Would Hurt Innovation

A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to

The Health 202: The drug industry keeps ramping up its spending on lobbying - Vimarsana News

The Health 202: The drug industry keeps ramping up its spending on lobbying

The Health 202: The drug industry keeps ramping up its spending on lobbying Paige Winfield Cunningham with Alexandra Ellerbeck The pharmaceutical industry keeps turning up the dial on lobbying, setting massive new spending records in its intensive effort to influence Congress and the Biden administration. Yet the administration isn’t capitulating to all of the industry’s demands. To be fair, the White House did back away from including an industry-hated drug pricing proposal in its latest spending plan. Yet this week, President Biden angered drugmakers when he said he...

Source: msn.com